Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares IssuedShares OutstandingShares Outstanding
Ratios

Greenwich LifeSciences (GLSI) Shares Issued (2020 - 2025)

Greenwich LifeSciences filings provide 4 years of Shares Issued readings, the most recent being $145000.0 for Q3 2025.

  • Quarterly Shares Issued fell 92.5% to $145000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Sep 2025, up 5.98% year-over-year, with the annual reading at $2.5 million for FY2024, N/A changed from the prior year.
  • Shares Issued hit $145000.0 in Q3 2025 for Greenwich LifeSciences, down from $2.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $2.6 million in Q2 2025 and bottomed at $145000.0 in Q3 2025.
  • Average Shares Issued over 3 years is $1.1 million, with a median of $527509.5 recorded in 2021.
  • The largest annual shift saw Shares Issued tumbled 97.65% in 2021 before it soared 877.82% in 2025.
  • Greenwich LifeSciences' Shares Issued stood at $562596.0 in 2021, then skyrocketed by 243.79% to $1.9 million in 2024, then tumbled by 92.5% to $145000.0 in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Shares Issued are $145000.0 (Q3 2025), $2.6 million (Q2 2025), and $492423.0 (Q1 2025).